| Citation: | LEI Jinzhi. Recent progresses in hematological dynamics[J]. Advances in Mechanics, 2012, 42(3): 294-313. doi: 10.6052/1000-0992/11-148
|
Hematopoiesis is a complex regulation system in human body, which is a typical nonlinear delay dynamical system, including proliferation, maturation and apoptosis of different types of blood cells, and feedback controls to these processes. Deregulations in the hematopoiesis can induce many dynamical blood diseases. Studies of hematological dynamics are important for understanding and treating these diseases. This paper surveys recent progresses in hematological dynamics studies, including basic knowledge of the hematopoiesis, clinical manifestation of dynamical blood disease and their dynamical characteristics, theoretical models and dynamical analysis.
|
1 Glass L, Mackey M. From Clocks to Chaos—The Rhythms of Life. New Jersey, Princeton University Press, 1975
|
|
2 Israels L, Israels E. Mechanisms in hematology. Core Health Services Inc, 2002
|
|
3 Adamson J. The relationship of erythropoietin and iron metabolism to red blood cell production in humans. Seminars in Oncology, 1999, 2: 9-15
|
|
4 Price T, Ghatta G, Dale D. Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood, 1999, 88: 335-340
|
|
5 Ratajckzak M, Ratajczak J, Marlicz W, et al. Recombinant human thrombopoietin(TPO) stimulates erythropoiesis by inhibiting erythroid progenitor cell apoptosis. British Journal of Haematology, 1997, 98: 8-17
|
|
6 Tanimukai S, Kimura T, Stakabe H, et al. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro. Experimental Hematology,1997, 25: 1025-1033
|
|
7 Foley C, Mackey M. Dynamic hematological disease: A review. Journal of Mathematical Biology, 2009, 58: 285-322
|
|
8 Mackey M, Milton J. Dynamical disease. Annals of the New York Academy of Sciences, 1987, 504: 16-32
|
|
9 Haurie C, Dale D, Mackey M. Occurrence of periodic oscillations in the differential blood counts of congenital, idiopathic, and cyclical neutropenic patients before and during treatment with G-CSF. Experimental Hematology,1999, 27: 401-409
|
|
10 Colijn C, Mackey M. A mathematical model of hematopoiesis: II. cyclical neutropenia. Journal of Theoretical Biology, 2005, 237: 133-146
|
|
11 Colijn C, Mackey M. A mathematical model of hematopoiesis: I. periodic myelogenous leukemia. Journal of Theoretical Biology, 2005, 237: 117-132
|
|
12 Apostu R, Mackey M. Understanding cyclical thrombocytopenia: A mathematical modeling approach. Journal of Theoretical Biology, 2008, 251: 297-316
|
|
13 Hammond W, Price T, Souza L, et al. Treatment of cyclic neutropenia with granulocyte colony stimulating factor. The New England Journal of Medicine, 1989, 320: 1306-1311
|
|
14 Vainstein V, Ginosara Y, Shohamb M, et al. The complex effect of granulocyte colony-stimulating factor on human granulopoiesis analyzed by a new physiologicallybased mathematical model. Journal of Theoretical Biology,2005, 234: 311-327
|
|
15 张伟, 胡海岩. 非线性动力学理论与应用的新进展. 北京: 科 学出版社, 2009
|
|
16 徐鉴, 裴利军. 时滞系统动力学近期研究进展与展望. 力学 进展, 2006, 36: 17-30
|
|
17 Lei J, Mackey M. Stochastic differential delay equation, moment stability, and application to hematopoietic stem cell regulation system. SIAM Journal on Applied Mathematics,2007, 67: 387-407
|
|
18 Lei J, Mackey M. Multistability in an age-structured model of hematopoiesis: Cyclical neutropenia. Journal of Theoretical Biology, 2011, 270: 143-153
|
|
19 Zhuge C, Lei J, Mackey M. Neutrophil dynamics in response to chemotherapy and G-CSF. Journal of Theoretical Biology, 2012, 293: 111-120
|
|
20 Bélair J, Mackey M. A model for the regulation of mammalian platelet. Annals of the New York Academy of Sciences,1987, 504: 280-282
|
|
21 Bélair J, Mackey M. Age-structure and two-delay models for erythropoiesis. Mathematical Biosciences, 1995, 128:317-346
|
|
22 Bernard S, Bélair J, Mackey M. Oscillations in cyclical neutrophenia: new evidence based on mathematical modeling. Journal of Theoretical Biology, 2003, 223: 283-298
|
|
23 Haurie C, Dale D, Rudnicki R, et al. Modeling complex neutrophil dynamics in the grey collie. Journal of Theoretical Biology, 2000, 192: 167-181
|
|
24 Haurie C, Mackey M, Dale D. Cyclical neutropenia and other periodic hematological disease: a review of mechanisms and mathematical models. Blood, 1998, 92: 2629-2640
|
|
25 Mackey M. Unified hypothesis for the origin of aplastic anemia and periodic hematopoiesis. Blood, 1978, 51: 941-956
|
|
26 Mackey M. Periodic anto-immune hemolytic anemia: an induced dynamical disease. Bulletin of Mathematical Biology,1979, 41: 829-834
|
|
27 Mahaffy J, Bélair J, Mackey M. Hematopoietic model with moving boundary condition and state dependent delay: application in erythropoiesis. Journal of Theoretical Biology,2000, 206: 585-603
|
|
28 Santillan M, Mahaffy J, Bélair J, et al. Regulation of platelet production: the normal response to perturbation and cyclical platelet disease. Journal of Theoretical Biology,2000, 206: 585-603
|
|
29 Mackey M. Mathematical models of hematopoietic cell replication and control. In: Othmer H, Adler F, Lewis M, et al. eds. Case Studies in Mathematical Modeling— -Ecology, Physiology and Cell Biology. New Jersey: Prentice-Hall, 1997. 151-182
|
|
30 Colijn C, Mackey M. Bifurcation and bistability in a model of hematopoietic regulation. SIAM Journal on Applied Dynamical Systems, 2007, 6: 378-394
|
|
31 Mackey M. Cell kinetic status of haematopoietic stem cells. Cell Prolif, 2001, 34: 71-83
|
|
32 Abkowitz J, Holly R, Hammond W. Cyclic hematopoiesis in dogs: studies of erythroid burst forming cells confirm and early stem cell defect. Experimental Hematology,1988, 16: 941-945
|
|
33 Beulter E, Lichtman M, Coller B, et al. Williams Hematology. New York: McGraw-Hill, 1995
|
|
34 Deubelbeiss K, Dancey J, Harker L, et al. Neutrophil kinetics in the dog. The Journal of Clinical Investigation,1975, 55: 833-839
|
|
35 Novak J, Necas E. Proliferation differentiation pathways of murine haematopoiesis: correlation of lineage fluxes. Cell Proliferation, 1994, 27: 597-633
|
|
36 Mackey M, Glass L. Oscillation and chaos in physiological control systems. Science, 1977, 197: 287-289
|
|
37 Lei J, Mackey M. Deterministic Brownian motion generated from differential delay equation. Physical Review E,2011, 84: 041105
|
|
38 Li D, Zheng Z. Multiple attractors and generalized synchronization in delayed Mackey-Glass systems. Chinese Physics B, 2008, 17: 4009-4013
|
|
39 Namajunas A, Pyragas K, Tamasevicius A. An electronic analog of the Mackey-Glass system. Physics Letters A,1995, 201: 42-46
|
|
40 R¨ost G, Wu J. Domain-decomposition method for the global dynamics of delay differential equations with unimodal feedback. Proceedings of the Royal Society A: Mathematical, Physical & Engineering Sciences, 2007,463: 2655-2669
|
|
41 Shahverdiev E, Nuriev R, Hashimov R, et al. Chaos synchronization between the Mackey-Glass systems with multiple time delays. Chaos Solitons & Fractals, 2006, 29:854-861
|
|
42 Sano S, Uchida A, Yoshimori S, et al. Dual synchronization of chaos in Mackey-Glass electronic circuits with time-delay feedback. Physical Review E, 2007, 75: 016207
|
|
43 Walther HO. The 2-dimensional attractor of dx= dt = ?? x(t)+f(x(t??1)). In: Memoirs of the American Mathematical Society, Vol. 544, Providence, RI, 1995.
|
|
44 Wei J, Fan D. Hopf bifurcation analysis in a Mackey-Glass system. International Journal of Bifurcation and Chaos,2007, 17: 2149-2157
|
|
45 Crawford J, Dale D, Lyman G. Chemotherapy-induced neutropenia: Risks, consequences, and new directions for its management. Cancer, 2003, 100: 228-237
|
|
46 Rahman Z, Esparza-Guerra L, Yap H, et al. Chemotherapy-induced neutropenia and fever in patients with metastasic breast carcinoma receiving salvage chemotherapy. Cancer, 1997, 79: 1150-1157
|
|
47 Skeel RT, ed. Handbook of Cancer Chemotherapy. 7th edn. New York: Lippincott Williams & Wilkins, 2007
|
|
48 Fogli S, Danesi R, Braud F, et al. Drug distribution and pharmacokinetic/pharmacodynamics relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer. Annals of Oncology, 2001, 12: 1553-1559
|
|
49 Gianni L, Kearns C, Giani A, et al. Nonlinear pharmacokinetics and metabolism of Palitaxel and its pharmacokinetic/ pharmacodynamics relationships in humans. Journal of Clinical Oncology, 2011, 13: 180-190
|
|
50 Henningsson A, Karlsson M, Viganó L, et al. Mechanismbased pharmacokinetic model for paclitaxel. Journal Clinical Oncology, 2001, 19: 4065-4073
|
|
51 Minkin, P, Zhao M, Chen Z, et al. Quantification of sunitinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2008, 874: 84-88
|
|
52 Mou C, Ganju N, Sridhar K, et al. Simultaneous quantitation of plasma doxorubicin and prochlorperazine content by high-performance liquid chromatography. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1997, 703: 217-224
|
|
53 Morikawa N, Mori T, Abe T, et al. Pharmacokinetics of methotrexate in plasma and cerebrospinal fluid. The Annals of Pharmacotherapy, 1997, 31: 1153-1156
|
|
54 Peng B, Hayes M, Resta D, et al. Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients. Journal of Clinical Oncology, 2004, 22: 935-942
|
|
55 Karl S, Mader I, Cristofanon S, et al. Histone deacetylase inhibitors prime medulloblastoma cells for chemotherapyinduced apoptosis by enhancing p53-dependent Bax activation. Oncogene, 2011, 30: 2275-2281
|
|
56 Brooks G, Langlois G, Lei J, et al. Neutrophil dynamics after chemotherapy and G-CSF: the role of pharmacokinetics in shaping the response. Journal of Theoretical Biology(submitted).
|
|
57 Marshall J. Control of Time-delay Systems. London: The Institution of Electrical Engineers, 1979
|
|
58 Butler R, Waites T, Lamar R, et al. Timing of G-CSF administration during intensive chemotherapy for breast cancer (abstract). American Society of Clinical Oncology,1992, 11: 1411
|
|
59 Koumakis G, Vassilomanolakis M, Barbounis V, et al. Optimal timing (preemptive versus supportive) of granulogyte colony-stimulating factor administration following high-dose cyclophosphamide. Oncology, 1999: 56: 28-35
|
|
60 Meisenberg B, Davis T, Melaragno R, et al. A comparison of therapeutic schedules for administering granulocyte colony-stimulating factor to nonhuman primates after high-dose chemotherapy. Blood, 1992, 79: 2267-2272
|
|
61 Morstyn G, Campbell L, Lieschke G, et al. Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy. Journal of Clinical Oncology, 1989, 7: 1554-1562
|
|
62 雷锦誌. 系统生物学—- 建模, 分析, 模拟. 上海: 上海科学 技术出版社, 2010
|
|
63 Colijn C, Foley C, Mackey M. G-CSF treatment of canine cyclical neutropenia: a comprehensive mathematical model. Experimental Hematology, 2007, 35: 898-907
|
|
64 Foley C, Bernard S, Mackey M. Cost-effective G-CSF therapy strategies for cyclical neutropenia: Mathematical modelling based hypotheses. Journal of Theoretical Biology, 2006, 238: 754-763
|
|
65 Zhuge C, Sun X, Lei J. On positive solutions and the Omega limit set for a class of delay differential equations. Journal of Dynamics and Differential Equations arXiv:1202.3529
|
|
66 Hearn T, Haurie C, Mackey M. Cyclical neutropenia and the periopherial control of white blood cell production. Journal of Theoretical Biology, 1998, 192: 167-181
|
|
67 Press W, Teukolsky S, Flannery B. Numerical Recipes in C. 2nd edn. Cambridge: Cambridge University, 1992
|
|
68 Henderson E, Lister T, Greaves M. Leukemia. London: Saunders, 1996
|
|
69 Fortin P, Mackey M. Periodic chronic myelogenous leukemia: Spectral analysis of blood cell counts and etiological implications. British Journal of Haematology,1999, 104: 336-345
|
|
70 Guerry D, Dale D, Omine M, et al. Periodic hematopoiesis in human cyclic neutropenia. The Journal of Clinical Investigation,1973, 52: 3220-3230
|
|
71 King-Smith E, Morley A. Computer simulation of granulopoiesis: normal and impaired granulopoiesis. Blood,1970, 36: 254-262
|
|
72 Morley A, King-Smith E, Stohlman F. The oscillatory nature of hemopoiesis. In: Stohlman F, ed. Hemopoietic Cellular Proliferation, New York: Grune & Stratton, 1969,3-14
|
|
73 Go R. Ideopathic cyclic thrombocytopenia. Blood Review,2005, 19: 53-59
|
|
74 Swinburne J, Mackey M. Cyclical thrombocytopenia: Characterisation by spectral analysis and a review. Journal of Theoretical Medicine, 2000, 2: 81-91
|
|
75 Cohen T, Cooney D. Cyclic thrombocytopenia: case report and review of literature. Scandinavian Journal of Haematology, 1974, 12: 9-17
|
|
76 von Schulthess G, Gessner U. Oscillating platelet counts in healthy individuals: Experimental investigation and quantitative evaluation of thrombocytopenia feedback control. Scandinavian Journal of Haematology, 1986, 36: 473-479
|
DownLoad: